These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 24036688)

  • 1. Serum 25-hydroxyvitamin D predicts severity in Parkinson's disease patients.
    Liu Y; Zhang BS
    Neurol Sci; 2014 Jan; 35(1):67-71. PubMed ID: 24036688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 25-hydroxyvitamin D, vitamin D receptor gene polymorphisms, and severity of Parkinson's disease.
    Suzuki M; Yoshioka M; Hashimoto M; Murakami M; Kawasaki K; Noya M; Takahashi D; Urashima M
    Mov Disord; 2012 Feb; 27(2):264-71. PubMed ID: 22213340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical correlates of serum 25-hydroxyvitamin D in Parkinson's disease.
    Barichella M; Cereda E; Iorio L; Pinelli G; Ferri V; Cassani E; Bolliri C; Caronni S; Pusani C; Schiaffino MG; Giana A; Quacci E; Esposito C; Monti Guarnieri F; Colombo A; Sorbo FD; Cilia R; Sacilotto G; Riboldazzi G; Zecchinelli AL; Pezzoli G
    Nutr Neurosci; 2022 Jun; 25(6):1128-1136. PubMed ID: 33151126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone mineral density and serum vitamin D status in Parkinson's disease: Are the stage and clinical features of the disease important?
    Ozturk EA; Gundogdu I; Tonuk B; Umay E; Kocer BG; Cakci A
    Neurol India; 2020; 68(2):394-400. PubMed ID: 32415013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Vitamin D in Disease Progression in Early Parkinson's Disease.
    Sleeman I; Aspray T; Lawson R; Coleman S; Duncan G; Khoo TK; Schoenmakers I; Rochester L; Burn D; Yarnall A
    J Parkinsons Dis; 2017; 7(4):669-675. PubMed ID: 28984616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitamin D and Sunlight Exposure in Newly-Diagnosed Parkinson's Disease.
    Wang J; Yang D; Yu Y; Shao G; Wang Q
    Nutrients; 2016 Mar; 8(3):142. PubMed ID: 26959053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between 25-Hydroxyvitamin D, bone density, and Parkinson's disease symptoms.
    Zhang HJ; Zhang JR; Mao CJ; Li K; Wang F; Chen J; Liu CF
    Acta Neurol Scand; 2019 Oct; 140(4):274-280. PubMed ID: 31389003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nocturnal blood pressure changes in Parkinson's disease: correlation with autonomic dysfunction and vitamin D levels.
    Arici Duz O; Helvaci Yilmaz N
    Acta Neurol Belg; 2020 Aug; 120(4):915-920. PubMed ID: 30847668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Abnormal bone and calcium metabolism in immobilized Parkinson's disease patients.
    Sato Y; Honda Y; Iwamoto J; Kanoko T; Satoh K
    Mov Disord; 2005 Dec; 20(12):1598-603. PubMed ID: 16114020
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulatory 25(OH)D and 1,25(OH)
    Ogura H; Hatip-Al-Khatib I; Suenaga M; Hatip FB; Mishima T; Fujioka S; Ouma S; Matsunaga Y; Tsuboi Y
    eNeurologicalSci; 2021 Dec; 25():100369. PubMed ID: 34611554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin D deficiency and its relationship with endothelial dysfunction in patients with early Parkinson's disease.
    Yoon JH; Park DK; Yong SW; Hong JM
    J Neural Transm (Vienna); 2015 Dec; 122(12):1685-91. PubMed ID: 26343034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of Rotigotine at Different Stages of Parkinson's Disease Symptom Severity and Disability: A Post Hoc Analysis According to Baseline Hoehn and Yahr Stage.
    Giladi N; Nicholas AP; Asgharnejad M; Dohin E; Woltering F; Bauer L; Poewe W
    J Parkinsons Dis; 2016 Oct; 6(4):741-749. PubMed ID: 27567886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum 25-hydroxyvitamin D levels in Chinese children with autism spectrum disorders.
    Gong ZL; Luo CM; Wang L; Shen L; Wei F; Tong RJ; Liu Y
    Neuroreport; 2014 Jan; 25(1):23-7. PubMed ID: 24089013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone mineral density and vitamin D status in Parkinson's disease patients.
    van den Bos F; Speelman AD; van Nimwegen M; van der Schouw YT; Backx FJ; Bloem BR; Munneke M; Verhaar HJ
    J Neurol; 2013 Mar; 260(3):754-60. PubMed ID: 23052606
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantifying iron deposition within the substantia nigra of Parkinson's disease by quantitative susceptibility mapping.
    An H; Zeng X; Niu T; Li G; Yang J; Zheng L; Zhou W; Liu H; Zhang M; Huang D; Li J
    J Neurol Sci; 2018 Mar; 386():46-52. PubMed ID: 29406966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between 25-hydroxy-vitamin D and Parkinson's disease.
    Xia M; Zhou Q
    IBRO Neurosci Rep; 2024 Jun; 16():162-167. PubMed ID: 38318343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased serum proNGF concentration in patients with Parkinson's disease.
    Xu XM; Dong MX; Feng X; Liu Y; Pan JX; Jia SY; Cao D; Wei YD
    Neurol Sci; 2018 Jan; 39(1):91-96. PubMed ID: 29052090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum 25-hydroxyvitamin D concentrations in Mid-adulthood and Parkinson's disease risk.
    Shrestha S; Lutsey PL; Alonso A; Huang X; Mosley TH; Chen H
    Mov Disord; 2016 Jul; 31(7):972-8. PubMed ID: 27090608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum levels of lipocalin-2 in patients with Parkinson's disease.
    Xiong M; Qian Q; Liang X; Wei YD
    Neurol Sci; 2022 Mar; 43(3):1755-1759. PubMed ID: 34455500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma homocysteine level and its relationship to clinical profile in Parkinson's disease patients at the Lagos University Teaching Hospital.
    Ojo OO; Oladipo OO; Ojini FI; Sanya EO; Danesi MA; Okubadejo NU
    West Afr J Med; 2011; 30(5):319-24. PubMed ID: 22752818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.